Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeCoNextions Inc.First Patient Treated with Coronet Soft Tissue Fixation System

First Patient Treated with Coronet Soft Tissue Fixation System

October 20, 2020

The first patient treated with Coronet Soft Tissue Fixation System was announced today by CoNextions Inc. Coronet Soft Tissue Fixation System in a Kidner procedure. The Kidner procedure is the most common surgical treatment for a painful accessory navicular bone that causes foot/tendon pain.

The Coronet Soft Tissue Fixation Systems is a tenodesis device intended for the fixation of soft tissue and tendon to bone.  During the Kidner procedure, a surgeon detaches the posterior tibial tendon from the bone and removes the pain-causing bone from the foot.  The posterior tibial tendon is then reattached to the navicular bone and secured with the Coronet.

Coronet’s novel design improves the soft tissue fixation strength of these repairs compared to conventional suture modalities.  A streamlined delivery system allows for the simultaneous placement of the implant in the bone and soft tissue and provides a knotless repair.  The Coronet is cleared for use by the FDA for the fixation of soft tissue to bone and tissue to tissue throughout numerous anatomical locations.  The first patient was treated by Youngstown, Ohio foot and ankle surgeon, Dr. Lawrence DiDomenico, at The Surgical Hospital at Southwoods.

“The Coronet was remarkably effective in streamlining the posterior tibial tendon reattachment portion of the Kidner procedure,” said Dr. DiDomenico.  “I am excited at the time efficiency the Coronet provided by not having to suture.  I also appreciate the ease of obtaining the appropriate tension with the Coronet versus suture.”

CoNextions Medical is currently launching the Coronet throughout the United States.  The device will be marketed by a network of orthopedic distributors across the country.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy